Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS SEPTEMBER ISSUE PUBLISHED
  • SEPTEMBER 2020 Issue has been successfully launched on 1 September 2020.

Abstract

FORMULATION AND EVALUATION OF IN-SITU OPTHALMIC GEL OF KETOROLAC TROMETHAMINE

*Sumegha Meshram, Surendra Kumar Jain, Nishiprakash Jain

Sagar Institute of Research & Technology - Pharmacy, Bhopal, India.

ABSTRACT

The poor bioavailability and therapeutic response exhibited by conventional ophthalmic solutions due to rapid precorneal elimination of drug may be overcome by the use of in-situ gel-forming systems that are instilled as drops into the eye and undergo a sol-gel transition.The aim of the present work was formulation and evaluation of in-situ gelling system of ketorolac tromethamine. Ketorolac tromethamine is an non-steroidal anti-inflammatory agent. The developed formulation can be used as an in-situ gelling vehicle to enhance ocular bioavailability. Carbopol 940 was used as the gelling agent in combination with HPMC K4M which acted as a viscosity enhancing agent. The prepared formulations were evaluated for pH, clarity, gelling capacity, in-vitro drug release, drug-excipient interactions (FTIR), and Short-term stability studies (402 C/755% RH for 3 months). IR spectroscopic studies indicated that there are no drug-excipient interactions. In-vitro drug release data of optimized formulation (K27) was treated according to Zero, First, Korsmeyer Peppas and Higuchi kinetics to access the mechanism of drug release. Eye irritation test using the HET-CAM test data of optimized formulation (K27) and calculated S value. The gel provided sustained drug release over an 9 hour period and the reduced frequency of instillation resulting in better patient acceptance.

Keywords: In-situ gel; Carbopol 940; Ketorolac tromethamine; HET-CAM test.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More